Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer.
暂无分享,去创建一个
D. Spaeth | I. Treilleux | T. Bachelot | M. Arnedos | J. Ferrero | E. Pujade-Lauraine | A. Lortholary | C. Lévy | E. Legouffe | C. Cropet | S. Abadie-Lacourtoisie | J. Eymard | Q. Wang | A. Bourcier